Aperam S.A. (GB:0OLF) has released an update.
Aperam S.A. forecasts Q2 2024 adjusted EBITDA to surpass Q1 but remain below early consensus estimates, amid operational challenges in Brazil and a price/cost squeeze in Europe. The company remains on track with its Leadership Journey Phase 5, aiming for EUR 75m gains in 2024, and expects a Q2 net debt decrease due to the release of net working capital. Current market trends show a positive price/volume correlation, but it is unclear if this signals a sustained recovery or temporary pre-summer buying.
For further insights into GB:0OLF stock, check out TipRanks’ Stock Analysis page.
